神經動力學

NeuroSky處於身心監測和分析的前沿。其技術是創新、可穿戴健康和保健消費產品的核心。NeuroSky使數百萬消費者能夠捕獲和量化關鍵的健康和健康數據，以便他們能夠有效地管理自己的身心健康。NeuroSky提供獨特的適應性芯片和算法，提供ECG多功能心髒監測，以及強大的集成、適應性和可擴展解決方案中的定量和解釋算法。

Wioptix是一家獲得SBIR IB期資助的公司，其項目名為:開發用於肺癌早期診斷的體內無創光學成像的微型內窺鏡成像探針。他們的第一階段項目將設計和製造直徑2.8毫米的光學相幹斷層掃描(OCT)成像mems探針。該計劃是應用MEMS設計和無線鍵合封裝技術來實現探頭的小型化。在這種MEMS設計中，反射鏡將具有高填充係數和在反射鏡表麵的相反芯片側的鍵合墊。MEMS反射鏡和其他光學元件將被封裝到MEMS探針中;探針將與現有的OCT係統連接，然後進行肺部成像測試。提出的基於mems的OCT係統有潛力成為在護理點快速診斷或篩查肺癌的低成本工具。該技術也有望用於其他OCT係統的內部器官成像。如果成功，所提出的MEMS設計和無線鍵合封裝技術幾乎可以應用於所有光學成像係統，包括相幹、共聚焦、非線性和自適應光學成像。它們也可用於激光掃描顯示和光學通信。 This effort may lead to the world's first MEMS-based OCT applicable to rapid diagnosis or screening of lung cancer at the point of care (e.g., bedside or office). Due to its low-cost and disposable nature, it is particularly suitable for field use without the need of sterilization equipments. Although the focus of this proposal is on a MEMS based endoscopic OCT system for bronchoscopy, the key technology developed can be adapted for other compact OCT systems for internal organ imaging. The MEMS-based endoscopic OCT probe is applicable to diagnosis and image-guided surgery of various internal cancers such as prostate, colon, rectal, and gastro-intestinal cancers. Wioptix is a company that received a SBIR Phase I grant for a project entitled: Development of Miniature Endoscopic Imaging Probes for In Vivo Noninvasive Optical Imaging for Early Diagnosis of Lung Cancer. Their Phase I project an Optical coherence tomography (OCT) imaging MEMS-based probe of 2.8 mm diameter will be designed and manufactured. The plan is to apply MEMS design and wire bonding free packaging techniques for miniaturization of the probe. In this MEMS design the mirror will have high fill factor and bonding pads on the opposite chip side of the reflective mirror surface. The MEMS mirror and the other optical component will be packaged into the MEMS-based probe; the probe will be attached with the existing OCT system, and then will be tested for lung imaging. The proposed MEMS-based OCT system has the potential to be a low-cost tool for rapid diagnosis or screening of lung cancer at the point of care. It is also expected that the technology could be used for other OCT systems for internal organ imaging. If successful the proposed MEMS design and wire bonding-free (WBF) packaging technique can be applied virtually to all optical imaging systems including coherence, confocal, nonlinear and adaptive optical imaging. They can also be used in laser scanning displays and optical telecommunications. This effort may lead to the world's first MEMS-based OCT applicable to rapid diagnosis or screening of lung cancer at the point of care (e.g., bedside or office). Due to its low-cost and disposable nature, it is particularly suitable for field use without the need of sterilization equipments. Although the focus of this proposal is on a MEMS based endoscopic OCT system for bronchoscopy, the key technology developed can be adapted for other compact OCT systems for internal organ imaging. The MEMS-based endoscopic OCT probe is applicable to diagnosis and image-guided surgery of various internal cancers such as prostate, colon, rectal, and gastro-intestinal cancers. "This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5)."

CryoPen是一家先進醫療設備和美容治療係統的開發商和製造商。CryoPen致力於為醫療保健提供者、所有專業的醫生和醫療水療中心提供最有效、最有利可圖的解決方案。該公司的產品組合旨在使醫生能夠提供更高質量的護理，並為患者提供更多樣化的治療，同時為他們的實踐產生可觀的收入流。CryoPen的產品集解決了多種治療應用，如激光脫毛，皮膚嫩膚，冷凍手術，脂肪團減少，血管病變，色素病變，痤瘡，牛皮癬，細紋和皺紋，疤痕和紋身去除，照片麵部，皮膚緊致。CryoPen致力於研究和開發技術先進的設備和設備，每一款產品都旨在創造更好的患者體驗，一致的臨床結果，並對其實踐的底線產生經濟影響。

Renovar, Inc.由國際公認的威斯康星大學麥迪遜分校移植外科醫生於1999年創立。該公司正在開發基於Renovar專利方法的腎髒疾病診斷測試和移植監測。該公司的方法結合了蛋白質生物標誌物和該公司的尿液緩衝係統，該係統允許分析尿液，否則不可能。該方法旨在實現非侵入性、更及時的疾病檢測，具有更高的靈敏度和特異性。

栗子醫療技術有限公司的成立是為了開拓新的微創治療介入神經放射學。Chestnut的目標是開發更容易使用的技術，同時改善治療神經血管疾病的結果並減少並發症。

NeoChord是一家醫療技術公司，致力於推進心髒搏動二尖瓣返流患者的二尖瓣修複。該公司的旗艦產品NeoChord人工索輸送係統是一種心髒跳動程序，回聲引導治療二尖瓣反流患者，並被證明可以解決和恢複正常的二尖瓣功能。該公司成立於2007年，總部位於明尼蘇達州的明尼阿波利斯。